1.	Contrast Enhanced MRI of the CNS - Patients With Known Cerebral Neoplastic Lesions. Phase: Phase IV Type: Diagnostic Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 91780, 2007-005693-31, 312021, NCT00764387
2.	SH L 562BB Phase II/III Dose Justification and Gadoteridol-controlled Comparative Study Phase: Phase III Type: Diagnostic Status: Completed Age: 20 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 91569, 310864, NCT00522951
3.	Gadobutrol Magnevist-controlled Body Study Phase: Phase III Type: Diagnostic Status: Completed Age: 20 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 13297, NCT01050829
4.	Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRI Phase: Phase III Type: Diagnostic Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 91743, GEMMA 1, 2009-009597-27, NCT01067976
5.	Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast Magnetic Resonance Imaging (MRI) Phase: Phase III Type: Diagnostic Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 91782, 2009-009598-90, NCT01104584